Patrick B Donnelly
Stock Analyst at Citi
(3.09)
# 2,476
Out of 4,345 analysts
558
Total ratings
45%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Initiated Coverage: Buy | $265 → $230 | $173.13 | +32.85% | 30 | May 27, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Buy | n/a | $13.42 | - | 13 | May 26, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | $1,550 | $1,093.84 | +41.70% | 18 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $35 → $28 | $15.38 | +82.05% | 5 | May 8, 2026 | |
| BRKR Bruker | Maintained: Hold | $40 → $44 | $48.62 | -9.50% | 29 | May 7, 2026 | |
| TECH Bio-Techne | Maintained: Buy | $80 → $70 | $48.09 | +45.56% | 21 | May 7, 2026 | |
| QDEL QuidelOrtho | Rated: Hold | $30 → $13 | $12.33 | +5.43% | 16 | May 6, 2026 | |
| MDLN Medline | Maintained: Buy | $60 → $55 | $35.84 | +53.46% | 4 | May 6, 2026 | |
| ILMN Illumina | Rated: Sell | $41 → $95 | $150.17 | -36.74% | 43 | May 4, 2026 | |
| AVTR Avantor | Maintained: Hold | $11 → $9 | $8.40 | +7.14% | 23 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $38 | $36.13 | +5.18% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $375 → $400 | $312.71 | +27.91% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $305.29 | -1.73% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $342.18 | +24.20% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $165.62 | +20.76% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 | $203.11 | +47.70% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $127.51 | +17.64% | 21 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $24 | $25.51 | -5.92% | 26 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $18.07 | +43.88% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $685 | $456.21 | +50.15% | 31 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 → $120 | $118.45 | +1.31% | 18 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 | $115.84 | +59.70% | 37 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $15.54 | +48.01% | 12 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $215 | $193.99 | +10.83% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 | $164.49 | +61.10% | 23 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 | $258.25 | +25.85% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $96.79 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $6 | $3.98 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $4.25 | $2.19 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $31.89 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $9.49 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 → $36 | $13.84 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $3.93 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 | $0.0004 | n/a | 1 | Nov 30, 2018 |
Danaher
May 27, 2026
Initiated Coverage: Buy
Price Target: $265 → $230
Current: $173.13
Upside: +32.85%
Fortrea Holdings
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.42
Upside: -
Mettler-Toledo International
May 8, 2026
Maintained: Buy
Price Target: $1,550
Current: $1,093.84
Upside: +41.70%
Caris Life Sciences
May 8, 2026
Maintained: Buy
Price Target: $35 → $28
Current: $15.38
Upside: +82.05%
Bruker
May 7, 2026
Maintained: Hold
Price Target: $40 → $44
Current: $48.62
Upside: -9.50%
Bio-Techne
May 7, 2026
Maintained: Buy
Price Target: $80 → $70
Current: $48.09
Upside: +45.56%
QuidelOrtho
May 6, 2026
Rated: Hold
Price Target: $30 → $13
Current: $12.33
Upside: +5.43%
Medline
May 6, 2026
Maintained: Buy
Price Target: $60 → $55
Current: $35.84
Upside: +53.46%
Illumina
May 4, 2026
Rated: Sell
Price Target: $41 → $95
Current: $150.17
Upside: -36.74%
Avantor
Apr 30, 2026
Maintained: Hold
Price Target: $11 → $9
Current: $8.40
Upside: +7.14%
Apr 29, 2026
Maintained: Hold
Price Target: $55 → $38
Current: $36.13
Upside: +5.18%
Apr 24, 2026
Maintained: Buy
Price Target: $375 → $400
Current: $312.71
Upside: +27.91%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $305.29
Upside: -1.73%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $342.18
Upside: +24.20%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $165.62
Upside: +20.76%
Apr 7, 2026
Maintained: Buy
Price Target: $300
Current: $203.11
Upside: +47.70%
Apr 7, 2026
Maintained: Buy
Price Target: $150
Current: $127.51
Upside: +17.64%
Apr 7, 2026
Rated: Hold
Price Target: $18 → $24
Current: $25.51
Upside: -5.92%
Apr 7, 2026
Maintained: Buy
Price Target: $26
Current: $18.07
Upside: +43.88%
Apr 6, 2026
Maintained: Buy
Price Target: $685
Current: $456.21
Upside: +50.15%
Mar 12, 2026
Rated: Hold
Price Target: $200 → $120
Current: $118.45
Upside: +1.31%
Mar 11, 2026
Maintained: Buy
Price Target: $185
Current: $115.84
Upside: +59.70%
Feb 25, 2026
Maintained: Buy
Price Target: $23
Current: $15.54
Upside: +48.01%
Feb 11, 2026
Maintained: Hold
Price Target: $215
Current: $193.99
Upside: +10.83%
Jan 15, 2026
Maintained: Buy
Price Target: $265
Current: $164.49
Upside: +61.10%
Jan 2, 2026
Maintained: Buy
Price Target: $325
Current: $258.25
Upside: +25.85%
May 22, 2025
Maintained: Buy
Price Target: $135
Current: $96.79
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $9 → $6
Current: $3.98
Upside: n/a
Mar 23, 2023
Maintained: Hold
Price Target: $1.5 → $4.25
Current: $2.19
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $62
Current: $31.89
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $6
Current: $9.49
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $32 → $36
Current: $13.84
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $3.93
Upside: n/a
Nov 30, 2018
Maintained: Hold
Price Target: $4.5
Current: $0.0004
Upside: n/a